Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Bilirubin (BIL), the end product of heme catabolism, is take...
| Class:Id | Summation:9661796 |
|---|---|
| _displayName | Bilirubin (BIL), the end product of heme catabolism, is take... |
| _timestamp | 2019-10-03 10:09:34 |
| created | [InstanceEdit:9661797] Jassal, Bijay, 2019-09-18 |
| modified | [InstanceEdit:9663471] Jassal, Bijay, 2019-10-02 [InstanceEdit:9663503] Jassal, Bijay, 2019-10-02 [InstanceEdit:9663529] Jassal, Bijay, 2019-10-03 |
| text | Bilirubin (BIL), the end product of heme catabolism, is taken up from the blood circulation into the liver. The organic anion transporting polypeptide (SLCO1B3, aka OATP-8, LST2, SLC21A8), localised on the basolateral (sinusoidal side) hepatocyte membrane, can mediate the uptake of BIL and various other lipophilic anions into the human liver (van de Steeg et al. 2012). |
| (summation) | [Reaction:9661799] SLCO1B3 transports BIL from extracellular region (blood) to cytosol (hepatocyte) [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Bilirubin (BIL), the end product of heme catabolism, is take... (9661796)
